JohnJFarleyJr.MD
Pediatric Endocrinology • Baltimore, MDClinical Associate Professor, Pediatrics, University of Maryland School of Medicine
Are you Dr. Farley?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-328-6749Fax+1 410-328-6136
Summary
- Dr. John Farley Jr., MD is a pediatric endocrinologist in Baltimore, Maryland. He is currently licensed to practice medicine in Maryland. He is a Clinical Associate Professor at University of Maryland School of Medicine.
Education & Training
Children's National HospitalResidency, Pediatrics, 1981 - 1985
George Washington University School of Medicine and Health SciencesClass of 1981
Certifications & Licensure
MD State Medical License 1985 - 2026- American Board of Pediatrics Pediatrics
Clinical Trials
- IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 57 citationsScreening for hazardous alcohol use and depressive symptomatology among HIV-infected patients in Nigeria: prevalence, predictors, and association with adherence.John Farley, Erin Miller, Andrew Zamani, Vicki Tepper, Chester Morris
Journal of the International Association of Physicians in AIDS Care. 2010-07-01 - 36 citationsClinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in NigeriaWalter Royal, Mariana Cherner, Jean K. Carr, Abdulrazaq Garba Habib, Abimbola Akomolafe
Journal of Neurovirology. 2012-04-18 - 45 citationsMedication Adherence in Children and Adolescents with HIV Infection: Associations with Behavioral ImpairmentKathleen Malee, Paige L. Williams, Grace Montepiedra, Marie McCabe, Sharon Nichols
AIDS Patient Care and Stds. 2011-03-06
Press Mentions
- FDA Approves New Drug To Prevent RSV in Babies and ToddlersJuly 18th, 2023
- FDA Approves First Monoclonal Injection To Prevent RSV in Infants, ToddlersJuly 25th, 2023
Grant Support
- Pharmaacokinetic Properties Of Antiretroviral Drugs During Pregnancy (Pactg P1)National Center For Research Resources2005
- Peer Education And Adherence To HIV Therapy In ChildrenEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
